UNICA IRIS Institutional Research Information System

SOLLA, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 144.233
NA - Nord America 8.336
AS - Asia 3.716
SA - Sud America 458
Continente sconosciuto - Info sul continente non disponibili 298
AF - Africa 82
OC - Oceania 29
Totale 157.152
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 142.091
US - Stati Uniti d'America 8.188
SG - Singapore 1.397
CN - Cina 1.259
UA - Ucraina 516
SE - Svezia 475
BR - Brasile 356
VN - Vietnam 352
DE - Germania 245
GB - Regno Unito 218
FI - Finlandia 216
FR - Francia 196
KR - Corea 120
IN - India 117
HK - Hong Kong 95
CA - Canada 91
BD - Bangladesh 68
JP - Giappone 47
NL - Olanda 47
IQ - Iraq 44
AR - Argentina 35
RU - Federazione Russa 34
PL - Polonia 30
PK - Pakistan 27
MX - Messico 24
ES - Italia 22
TR - Turchia 21
ID - Indonesia 20
AT - Austria 19
AU - Australia 19
BE - Belgio 19
RO - Romania 18
ZA - Sudafrica 18
IL - Israele 16
VE - Venezuela 16
IR - Iran 14
MA - Marocco 14
CL - Cile 13
CZ - Repubblica Ceca 13
SA - Arabia Saudita 13
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 12
CU - Cuba 11
JO - Giordania 11
CH - Svizzera 10
IE - Irlanda 10
EC - Ecuador 9
KE - Kenya 9
NZ - Nuova Zelanda 9
JM - Giamaica 8
MY - Malesia 8
PT - Portogallo 8
PY - Paraguay 8
CO - Colombia 7
EG - Egitto 7
GR - Grecia 7
OM - Oman 7
PH - Filippine 7
TH - Thailandia 7
TW - Taiwan 7
EU - Europa 6
GH - Ghana 6
LT - Lituania 6
TN - Tunisia 6
BG - Bulgaria 5
BO - Bolivia 5
CI - Costa d'Avorio 5
PE - Perù 5
AZ - Azerbaigian 4
DK - Danimarca 4
EE - Estonia 4
KZ - Kazakistan 4
LB - Libano 4
PA - Panama 4
UY - Uruguay 4
CY - Cipro 3
DZ - Algeria 3
KG - Kirghizistan 3
LV - Lettonia 3
NP - Nepal 3
SN - Senegal 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
AO - Angola 2
BY - Bielorussia 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
IS - Islanda 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
MU - Mauritius 2
NG - Nigeria 2
NI - Nicaragua 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BB - Barbados 1
BJ - Benin 1
BS - Bahamas 1
BW - Botswana 1
Totale 156.841
Salva come PNG Salva come JPEG
Città #
Cagliari 138.990
Uta 2.449
Singapore 731
Ashburn 713
Fairfield 672
Woodbridge 583
Chandler 543
San Jose 483
Houston 373
Boardman 331
Wilmington 304
Nyköping 296
Dallas 293
Beijing 271
Seattle 270
Ann Arbor 267
Jacksonville 255
Cambridge 204
Dearborn 190
Los Angeles 159
Santa Clara 148
Helsinki 128
Council Bluffs 114
Shanghai 114
Nanjing 106
New York 101
Lauterbourg 98
Ho Chi Minh City 97
The Dalles 92
Hong Kong 84
Hefei 80
Boston 76
Hanoi 72
Seoul 72
Milan 62
Buffalo 61
Redwood City 51
San Diego 51
Rome 49
Orem 42
Toronto 39
Atlanta 37
Sassari 37
São Paulo 36
Shenyang 34
Dong Ket 32
London 31
Changsha 29
Frankfurt am Main 29
Chicago 28
Nanchang 25
Warsaw 25
San Francisco 24
Phoenix 23
Redondo Beach 23
Brooklyn 22
Tianjin 22
Tokyo 22
Da Nang 21
Guangzhou 21
Jiaxing 21
Munich 21
Chennai 19
Mountain View 19
Norwalk 19
Haiphong 18
Verona 18
Brussels 17
Baghdad 16
Washington 16
Hebei 15
Rio de Janeiro 15
Amsterdam 14
Icheon-si 14
Orange 14
Wuhan 14
Dhaka 13
Jinan 13
Manchester 13
Montreal 13
Nuremberg 13
Zhengzhou 13
Denver 12
Mumbai 11
Ningbo 11
Pune 11
Tashkent 11
Yongin-si 11
Amman 10
Augusta 10
Bari 10
Miami 10
Auburn Hills 9
Lahore 9
Las Vegas 9
Porto Alegre 9
Stockholm 9
Casablanca 8
Deva 8
Erbil 8
Totale 151.159
Salva come PNG Salva come JPEG
Nome #
Mucuna pruriens (Velvet bean) Rescues Motor, Olfactory, Mitochondrial and Synaptic Impairment in PINK1(B9) Drosophila melanogaster Genetic Model of Parkinson's Disease 5.435
Drosophila model for parkinson’s disease: function, anatomy and screening with phytoterapics from Sardinian and Indian flora (Withania somnifera and Mucuna pruriens) 5.082
Functional and morphological correlates in the drosophila LRRK2 loss-of-function model of Parkinson's disease: drug effects of Withania somnifera (Dunal) administration 5.024
Effect of olfactory and gustatory dysfunction and motor symptoms on body weight in patients with Parkinson’s disease 4.472
C9ORF72 intermediate repeat expansion in patients affected by atypical Parkinsonian syndromes or parkinson’s disease complicated by psychosis or dementia in a Sardinian population 4.290
OLFACTORY DYSFUNCTION AS POTENTIAL BIOMARKER IN NEURODEGENERATIVE DISORDERS 4.044
Drosophila mutant model of Parkinson's disease revealed an unexpected olfactory performance: Morphofunctional evidences 3.868
Impaired sense of smell in a Drosophila Parkinson's model. 3.666
Metabolomics as a Tool for the characterization of Drug-resistant epilepsy 3.544
Drosophila Parkinson's mutant display olfactory impairment both to natural and synthetic compounds 3.513
Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 3.478
Pisa-Like Syndrome Under Baclofen in a Patient With Spastic Hemiparesis due to Ischemic Stroke 3.184
Focal 123I-FP-CIT SPECT abnormality in a patient with midbrain vascular Parkinsonism 3.103
Olfactory function and apathy as potential biomarker in patients with Parkinson's disease 3.036
The imbalance of serotonergic circuitry impairing the crop supercontractile muscle activity and the mitochondrial morphology of PD PINK1B9 Drosophila melanogaster are rescued by Mucuna pruriens 3.031
An unusual delusion of duplication in a patient affected by Dementia with Lewy bodies 2.941
Influence of parkinsonism on Hitler's decision-making 2.918
Olfactory function and age: a sniffin’ sticks extended test study performed in Sardinia 2.918
Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel 2.504
Gender differences in olfactory function in patients with Parkinson's disease. 2.470
Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion 2.358
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 2.311
Occurence and DAergic therapy correlates of REM sleep behavior disorder in patients with Parkinson Disease 2.169
Autonomic imbalance in Parkinson's disease patients with or without LRRK2 gene mutations 2.164
Suicide and Dopamine Agonist Withdrawal Syndrome in Parkinson's Disease 2.128
Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: Importance of G2019S and R1441C mutations in sporadic Parkinson’s disease patients 2.065
Medulloblastoma induces unusual headache with clinical picture of basilar-type migraine complicated by ischaemic infarcts 2.061
Clinical metabolomics and hematic ADMA predict the future onset of cardiorenal syndrome in young grown-up subjects who were born preterm 2.060
Reversible Pisa syndrome in patients with Parkinson's disease on dopaminergic therapy 2.019
Association between fatigue and other motor and non-motor symptoms in Parkinson's disease patients 1.929
Heat shock protein 27 R127W mutation: evidence of a continuum between axonal Charcot-Marie-Tooth and distal hereditary motor neuropathy 1.902
Parkin exon rearrangements and sequence variants in LRRK2 mutations carriers: analysis on a possible modifier effects on LRRK2 penetrance 1.892
Discordance between Dopamine transporter deficit and motor symptoms in a case of REM sleep behavior disorder 1.888
Leucine-rich repeat kinase 2 (LRRK2) gene mutations in degenerative parkinsonism 1.689
Internal carotid artery dissection causing ischemic stroke during pole sport practice 1.561
Impact of supporting people with advanced Parkinson’s disease on carer’s quality of life and burden 1.553
null 1.548
Usefulness of levodopa in the treatment of patients affected by schizophrenia and parkinsonism with DAT scan suggestive of a severe presinaptic dopaminergic deficiency 1.517
Caregiver burden and its related factors in advanced Parkinson’s disease: data from the PREDICT study 1.427
null 1.368
Hypersexual behaviour, frotteurism and delusional jealousy in a young parkinsonian patient during dopaminergic therapy with pergolide: A rare case of iatrogenic paraphilia 1.352
Towards the characterization of the role of neurosteroids in pathological gambling: Clinical and preclinical studies 1.333
Clinical evaluation of sleep disorders in a large population of Parkinsonians 1.326
Delayed effect of age at onset on disability progression in multiple sclerosis 1.310
Occurrence and Daergic therapy correlates of REM sleep behaviour disorder in a large population of patients with Parkinson's disease 1.303
Axonal Charcot-Marie-Tooth disease, distal hereditary motor neuropathy and spastic paraplegia in a large Sardinian family with Heat Shock Protein RW mutation: an expression of a common spectrum? 1.248
Analysis of parkin exon rearrangements and sequence variants in LRRK2 mutations carriers 1.121
Genetic analysis for five LRRK2 mutations in sardinian patients with familial or sporadic Parkinson’s disease 1.101
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study 1.060
Factors Influencing Adaptation and Performance at Physical Exercise in Complex Congenital Heart Diseases after Surgical Repair 1.058
Delusional jealousy in Parkinson's disease patients with and without dementia 1.034
Occurance and Daergic therapy correlates of REM sleep behaviour disorder in a large population of patients with Parkinson's disease 1.029
Bipolar affective disorder and Parkinson's disease: a rare, insidious and often unrecognized association 1.001
Clozapine-induced persistent hiccup in a patient with Alzheimer's disease. 963
Presence and severity of apathy in Sardinian patients affected by Parkinson’s disease and correlation with non-motor symptoms 939
Dopamine dysregulation syndrome in Parkinson's disease patients with unsatisfactory switching from immediate to extended release pramipexole: a further clue to incentive sensitization mechanisms? 907
Parkin sequence variants in Parkinson’s disease patients with LRRK2 mutations 887
Levodopa/carbidopa/entacapone-induced acute Pisa syndrome in a Parkinson's disease patient 881
Dopamine dysregulation syndrome in Parkinson's disease patients on duodenal levodopa infusion 875
Frequency and Determinants of Olfactory Hallucinations in Parkinson’s Disease Patients 868
Rasagiline withdrawal Syndrome in Parkinson’s Disease 849
Olfactory impairment in Parkinson’s disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype: a pilot study 845
The p.A382T TARDBP gene mutation in Sardinian patients affected by Parkinson's disease and other degenerative parkinsonisms 820
A top-down proteomic approach reveals a salivary protein profile able to classify Parkinson's disease with respect to Alzheimer's disease patients and to healthy controls 801
Does Olfactory Dysfunction Correlate with Disease Progression in Parkinson’s Disease? A Systematic Review of the Current Literature 799
Sintomi non motori e disautonomia cardiovascolare in pazienti sardi affetti da malattia di parkinson con e senza mutazioni del gene LRRK2 796
Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease 748
Olfactory Impairment Correlates with Executive Functions Disorders and Other Specific Cognitive Dysfunctions in Parkinson’s Disease 743
Finasteride attenuates pathological gambling in patients with Parkinson disease 717
null 692
Association between olfactory dysfunction and motor subtypes in Parkinson’s disease: are non‑tremor‑dominant subtypes really uncorrelated to olfactory impairment? 647
Olfactory hallucinations in Parkinson’s disease patients and the role of their evaluation in clinical practice. 644
Othello syndrome in Parkinson disease patients without dementia 618
Phantosmia in Parkinson’s Disease: A Systematic Review of the Phenomenology of Olfactory Hallucinations. 594
Gender-Related Differences in the Correlation between Odor Threshold, Discrimination, Identification, and Cognitive Reserve Index in Healthy Subjects 594
Lateral trunk flexion and Pisa syndrome in Parkinson's disease. Are they really always different conditions although denoting similar features? 580
Pisa syndrome in a patient with progressive supranuclear palsy 575
Discordance between dopamine transporter deficit and motor symptoms in a case of REM behaviour disorder 574
Dopaminergic-induced paraphilias associated with impulse control and related disorders in patients with Parkinson disease 566
Pathological gambling, delusional parasitosis and adipsia as a post-haemorrhagic syndrome: a case report 554
[123I] FP-CIT single photon emission computed tomography findings in drug-induced parkinsonism 540
Aberrant sexual behaviours in Parkinson's disease during dopaminergic treatment 537
Paraphilic behaviours in a parkinsonian patient with hedonistic homeostatic dysregulation 517
Treatment of Benign Essential Blepharospasm With Finasteride: A Case Report 513
Olfactory Impairment Is the Main Predictor of Higher Scores at REM Sleep Behavior Disorder (RBD) Screening Questionnaire in Parkinson’s Disease Patients 510
Reversible Pisa syndrome in Parkinson's disease during treatment with pergolide: a case report 492
[I-123]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism 482
Motor and non-motor disorders in parkinsonian patients with LRRK2 mutations 477
Exposure to TNF inhibitors is rare at MOGAD presentation 473
null 463
Behavioral, neuropsychiatric and cognitive disorders in Parkinson's disease patients with and without motor complications 462
Role of rapid eye movement sleep behavior disorder (RBD) and other clinical factors in the prediction of cognitive impairment in Parkinson’s disease 423
Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo (R)) 421
Epilepsy and sexual funtcion in male and female subjects treated with old and new AEDs, on poly or monotherapy: Preliminary data (Conference Paper) [Epilessia e funzione sessuale in pazienti di sesso maschile e femminile trattati con vecchi e nuovi FAE, in poli e monoterapia: Dati preliminari] 421
Protein Tyrosine phosphatase receptor type C (CD45) C77G mutation and susceptibility to multiple sclerosis, autoimmune and infectious diseases 405
Atypical parkinsonism in a patient with LRRK2 R1441c mutation 388
Compulsive original artistic creativity in Parkinson's disease: a new dimension of the spectrum of reward-seeking behaviours 359
Dopaminergic replacement therapy enhances artistic productivity in patients with Parkinson's disease 352
Olfactory Function as a Potential Predictor of Cognitive Impairment in Men and Women 345
Neurological and Psychiatric Disorders in the COVID-19 Era 340
Totale 154.402
Salva come PNG Salva come JPEG
Categoria #
all - tutte 202.769
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 202.769
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.795 0 488 284 468 568 509 376 346 536 639 784 797
2022/20239.178 750 1.110 1.155 739 789 872 467 887 561 655 735 458
2023/202410.056 572 543 420 792 919 1.368 1.258 741 532 810 1.065 1.036
2024/202517.352 2.798 3.463 2.267 4.022 1.164 1.304 1.089 147 366 206 230 296
2025/20266.570 480 292 638 565 534 603 942 430 533 907 378 268
2026/2027459 455 4 0 0 0 0 0 0 0 0 0 0
Totale 157.152